Please use this identifier to cite or link to this item:
https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/4231
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chia, John W K | - |
dc.contributor.author | Segelov, Eva | - |
dc.contributor.author | Deng, Yanhong | - |
dc.contributor.author | Fuang Ho, Gwo | - |
dc.contributor.author | Wang, Wei | - |
dc.contributor.author | Han, Shuting | - |
dc.contributor.author | Sharma, Atul | - |
dc.contributor.author | Ding, Kefeng | - |
dc.contributor.author | Chen, Gong | - |
dc.contributor.author | Jeffery, Mark G | - |
dc.contributor.author | Kian Tham, Chee | - |
dc.contributor.author | Nott, Louise | - |
dc.contributor.author | Bae Ahn, Joong | - |
dc.contributor.author | Zielinski, Robert | - |
dc.contributor.author | Chao, Tsu-Yi | - |
dc.contributor.author | Van Hagen, Tom | - |
dc.contributor.author | Wei, Po-Li | - |
dc.contributor.author | Day, Fiona | - |
dc.contributor.author | Mehta, Shaesta | - |
dc.contributor.author | Yau, Thomas | - |
dc.contributor.author | Peng, Jiewen | - |
dc.contributor.author | Li, Yong | - |
dc.contributor.author | Gandhi, Mihir | - |
dc.contributor.author | Foo MCouns, Estelle M J | - |
dc.contributor.author | Rahman, Nabilah | - |
dc.contributor.author | Rothwell, Peter | - |
dc.contributor.author | Ali, Raghib | - |
dc.contributor.author | Simes, John | - |
dc.contributor.author | Chong Toh, Han | - |
dc.date.accessioned | 2025-02-17T00:14:20Z | - |
dc.date.available | 2025-02-17T00:14:20Z | - |
dc.date.issued | 2025-03 | - |
dc.identifier.issn | 2468-1156 Online | en |
dc.identifier.issn | 2468-1253 Print | en |
dc.identifier.uri | https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/4231 | - |
dc.description.abstract | Aspirin is a simple, globally available medication that has been shown to reduce the incidence of colorectal cancer. We aimed to evaluate the safety and efficacy of aspirin in the secondary prevention of colorectal cancer. | en |
dc.subject | Aspirin | en |
dc.subject | Colorectal | en |
dc.subject | Cancer | en |
dc.subject | Trial | en |
dc.subject | Placebo | en |
dc.subject | Medication | en |
dc.subject | Efficiency | en |
dc.subject | Dukes B | en |
dc.title | Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | The Lancet Gastroenterology & Hepatology | en |
dc.accession.number | S2468-1253(24)00387-X | en |
dc.identifier.url | https://doi.org/10.1016/S2468-1253(24)00387-X | en |
dc.format.startpage | 198 | en |
dc.source.volume | 10 | en |
local.issue.number | 3 | en |
dc.identifier.database | ScienceDirect | en |
dc.format.pages | 198-209 | en |
dc.identifier.importdoi | 10.1016/S2468-1253(24)00387-X | en |
dc.type.studyortrial | Randomized Controlled Clinical Trial/Controlled Clinical Trial | en |
dc.contributor.swhauthor | Hayes, Theresa M | - |
Appears in Collections: | SWH Staff Publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.